MARKET RADAR
SENSEX     NIFTY      Refresh

UTI Pharma & Healthcare Fund (D)

31.230
0.09 (0.29%)
NAV as on May-28-2012

Not Ranked

This scheme is not ranked by CRISIL.
View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on May-28-2012)

Period Returns (%) Rank #
1 mth -3.0 3
3 mth 2.5 3
6 mth 3.1 3
1 year -0.5 3
2 year 6.9 2
3 year 24.3 2
5 year 12.0 2

# Moneycontrol Rank within 3 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2012 6.9 - - - -
2011 -7.8 6.1 -7.2 -0.7 -10.0
2010 11.7 8.9 1.4 4.1 30.1
2009 -1.3 18.2 25.0 -0.2 65.6
2008 -15.6 9.7 -7.5 -18.5 -31.7
2007 -4.4 13.3 -6.5 10.6 10.6

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns -3.0 2.5 3.1 -0.5 6.9 24.3 12.0
Category avg -2.3 5.8 7.2 5.1 9.8 27.1 12.9
Difference of Fund returns and Category returns -0.7 -3.3 -4.1 -5.6 -2.9 -2.8 -0.9
Best of category -2.0 5.9 9.3 7.7 10.8 31.0 19.6
Worst of category -3.0 2.5 3.1 -0.5 6.3 24.2 6.3
Benchmark returns # -1.6 5.2 8.6 6.9 12.0 -- --
Difference of Fund returns and Benchmark returns -1.4 -2.7 -5.5 -7.4 -5.1 24.3 12.0
# Benchmark Index: CNX Pharma

Investment Info

Investment Objective

Investment will be made in stocks of companies engaged in manufacturing of Pharmaceuticals bulk drugs, formulations & OTC drugs, medical equipment and accessories, personal healthcare products and also companies owning/managing hospitals etc.

Scheme details

Fund Type Open-Ended
Investment Plan Dividend
Launch date Jun 26, 1999
Benchmark CNX Pharma
Asset Size (Rs cr) 93.37 (Mar-31-2012)
Minimum Investment Rs.5000
Last Dividend Rs.1.70 (Oct-28-2010) View Dividend History
Bonus N.A.
Fund Manager Lalit Nambiar
View performance of schemes managed by the Fund Manager
Notes UTI Pharma & Healthcare Fund - Income Option Newly introduced w.e.f August 01, 2005.

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit Load 1% if redeemed within 1 Year from the date of allotment.

Contact Details

Regd. Office UTI Tower, Gn Block, Bandra-Kurla Complex, Bandra (E), Mumbai, 400051
Tel. No. 66786666
Fax No. 26524921
Email uti@giasbm01.vsnl.net.in
Website http://www.utimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
563.56 3.6 7.4 0.5 31.0 19.6
SBI Magnum Pharma Fund (G) Not Ranked
41.05 5.9 9.3 7.7 24.2 6.3
UTI Pharma & Health (G) Not Ranked
93.37 2.5 3.1 -0.5 24.3 12.0
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Apr 30, 12)

Equity Sector Value
(Rs cr)
Asset %
Sun Pharma Pharmaceuticals - 17.36
Dr Reddys Labs Pharmaceuticals - 17.34
Lupin Pharmaceuticals - 9.99
Cipla Pharmaceuticals - 9.73
GlaxoSmithKline Pharmaceuticals - 6.99
Wyeth Pharmaceuticals - 5.61
Pfizer Pharmaceuticals - 4.80
Cadila Health Pharmaceuticals - 4.73
Divis Labs Pharmaceuticals - 3.97
Biocon Pharmaceuticals - 3.23

Full Portfolio

Sector Allocation (Apr 30, 12)

Sector %

1-Year

HighLow

Pharmaceuticals 94.72 95.75 90.53

View All Sectors

Asset Allocation (%)(Apr 30, 12)

Equity 94.72
Others 0.00
Debt 1.33
Mutual Funds N.A
Money Market 0.00
Cash / Call 3.94

View All

Concentration

Holdings (%)
Top 5 61.41
Top 10 83.75
Sector (%)
Top 3 94.72

News & Videos

Messages & Community